Navigation Links
Dr. Derek Winstanly of Quintiles to Serve as 2009 ACRO Chair; Mr. William Sharbaugh of PPD to Be Chair-Elect
Date:1/13/2009

ICON Joins as Associate Member

WASHINGTON, Jan. 13 /PRNewswire-USNewswire/ -- The Association of Clinical Research Organizations (ACRO), which represents the clinical outsourcing industry to regulators, biopharmaceutical clients, policy makers and the public in the U.S. and worldwide, today announced that it has elected Dr. Derek Winstanly as Chair for 2009 and Mr. William Sharbaugh as Chair-Elect.

Dr. Winstanly, MBChB, Executive Vice President of Strategic Business Partnerships for Quintiles Transnational, and Mr. Sharbaugh, Chief Operating Officer of PPD, were elected at the association's annual meeting in December. Dr. Winstanly is a respected leader of the clinical research organization (CRO) industry, having held various global leadership positions within Quintiles since joining the company in 1999. In his current role, as Executive Vice President, he works with senior biopharmaceutical executives to provide long-term strategic solutions, and is responsible for the Office of the Chief Medical Officer as well as the ethics and quality assurance functions of the company.

Mr. Sharbaugh joined PPD in 2007 after spending more than 16 years in the pharmaceutical industry, including senior management positions with Bristol-Myers Squibb and Merck & Co. As COO, he provides strategic direction and leadership to PPD's Phase II-IV clinical business, global central labs, information technology and human resources.

"I am delighted to lead ACRO in 2009 and to help set the organization's strategic agenda during this crucial period of development for the CRO industry," said Dr. Winstanly. "The long-term future for the CRO industry remains bright and we look forward to working with our clients, regulators and legislators globally to bring about a more efficient drug development paradigm while maintaining the highest standards of patient safety."

ACRO is also pleased to announce the addition of ICON plc as an associate member. ICON, based in Dublin, Ireland, is a full service CRO that currently has more than 6,500 employees working in 38 countries.

"Dr. Winstanly and Mr. Sharbaugh bring tremendous vision and commitment to the ACRO leadership team," said ACRO Executive Director Doug Peddicord, Ph.D. "As one of the leading global CROs, we welcome ICON into the association and, as always, we will work to provide exceptional value for all of our members."

About ACRO

The Association of Clinical Research Organizations (ACRO) is the professional organization of companies whose focus is clinical research. The association provides an active voice for the CRO industry, which provides specialized services that are integral to the development of drugs, biologics and medical devices. ACRO helps its members improve the quality, efficiency and safety of biomedical research. ACRO member companies employ more than 72,000 professionals worldwide. For more information, please visit www.acrohealth.org.


'/>"/>
SOURCE Association of Clinical Research Organizations
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Association of Clinical Research Organizations (ACRO) Names Dr. Derek Winstanly Chair-Elect
2. Honor Society of Nursing Recognizes Researcher of HIV Risk Prevention for Poor and Underserved
3. Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients
4. Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois
5. Snapshots of Eyes Could Serve as Early Warning of Diabetes or Diabetic Eye Disease, U-M Researchers Report
6. BioNumerik Pharmaceuticals Observes Evidence of a Survival Increase in Lung Cancer Patients Participating in Tavocept(TM) Clinical Trial
7. Photos: SOS Childrens Villages Observes World Orphan Week, October 5-11, 2008
8. Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference
9. William R. Ringo Joins Hyperion Therapeutics, Inc. Board of Directors as Chairman
10. Velcura Therapeutics, Inc. Adds William Brinkerhoff to its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... 2016  The ALS Association, in partnership with ALS Finding ... generate a biomarker to track TDP43 aggregation. The successful team(s) ... $1 million investment. --> ... nerve cells in the brain and the spinal cord. Eventually, ... muscle movement, which often leads to total paralysis and death ...
(Date:2/10/2016)... VIEW, Calif. , Feb. 10, 2016 ... of a synergistic confluence of various technologies ... value propositions, previously unavailable. These opportunities create ... and convergence, in turn, drives the development ... entrepreneurial scenario is characterized by technology convergences, ...
(Date:2/10/2016)... 2016 Antibacterial Drugs Market - Global ... 2023 ", reveals that the global antibacterial drugs market is ... 2023 owing to patent expiries of blockbuster drugs. Even though ... the forecast period, the value is anticipated to decline from ... --> Antibacterial Drugs Market - Global Industry Analysis, Size, ...
Breaking Medicine Technology:
(Date:2/10/2016)... ... ... Gout is like no other joint pain. It strikes suddenly, like flicking on ... redness. It is triggered by the crystallization of uric acid within the joints. It ... to the February 2016 issue of Harvard Men's Health Watch. , The large joint ...
(Date:2/10/2016)... Carefree, AZ (PRWEB) , ... February 10, 2016 , ... ... coach in new book , Pioneering book "Better with Age: The Ultimate Guide to ... neuroplasticity can improve memory. The book’s publication date is March 16, 2016. ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... FL 32224, February 26th: Amateur & Professional Divisions - Time: 7:00pm – ... – 10:00pm | Ticket Prices $30, Social Media: http://www.USPoleSportsFed.org , Facebook: ...
(Date:2/10/2016)... ... ... A new leadership team for Mid-South Youth Camp, operated by Freed-Hardeman University, will ... night, Feb. 8, prior to the evening session of the university’s 80th Annual Bible ... Camp, has been named director. Gayle McDonald, currently the assistant director of MSYC, will ...
(Date:2/10/2016)... ... ... It’s that time of year when most people have forgotten all about their New ... (IAAM), Hall of Fame athlete and Garrison Forest School athletic director since 2005, knows ... of her first decisions when her IAAM two-year presidency began last July was to ...
Breaking Medicine News(10 mins):